Muscarinic receptor antagonist activity of diacylglycerol lipase and kinase inhibitors
Mahendran Sekar(Monash University Malaysia), Lowell E. Hokin(University of Wisconsin System), Ronald E. Pruitt(Nashville Medical Research Institute), Kenneth E.J. Dickinson(Bristol-Myers Squibb (United States)), Basil I. Hirschowitz(University of Alabama at Birmingham)
Cited by 4
Related Papers
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
Microplastic sources, formation, toxicity and remediation: a review
|Environmental Chemistry Letters|2023|776
A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
|Frontiers in Pharmacology|2022|457